Correlation Between Immunome and Anixa Biosciences
Can any of the company-specific risk be diversified away by investing in both Immunome and Anixa Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immunome and Anixa Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immunome and Anixa Biosciences, you can compare the effects of market volatilities on Immunome and Anixa Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immunome with a short position of Anixa Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immunome and Anixa Biosciences.
Diversification Opportunities for Immunome and Anixa Biosciences
0.18 | Correlation Coefficient |
Average diversification
The 3 months correlation between Immunome and Anixa is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Immunome and Anixa Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anixa Biosciences and Immunome is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immunome are associated (or correlated) with Anixa Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anixa Biosciences has no effect on the direction of Immunome i.e., Immunome and Anixa Biosciences go up and down completely randomly.
Pair Corralation between Immunome and Anixa Biosciences
Given the investment horizon of 90 days Immunome is expected to generate 1.17 times more return on investment than Anixa Biosciences. However, Immunome is 1.17 times more volatile than Anixa Biosciences. It trades about 0.06 of its potential returns per unit of risk. Anixa Biosciences is currently generating about 0.01 per unit of risk. If you would invest 730.00 in Immunome on September 12, 2024 and sell it today you would earn a total of 660.00 from holding Immunome or generate 90.41% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Immunome vs. Anixa Biosciences
Performance |
Timeline |
Immunome |
Anixa Biosciences |
Immunome and Anixa Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Immunome and Anixa Biosciences
The main advantage of trading using opposite Immunome and Anixa Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immunome position performs unexpectedly, Anixa Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anixa Biosciences will offset losses from the drop in Anixa Biosciences' long position.Immunome vs. Anebulo Pharmaceuticals | Immunome vs. Adagene | Immunome vs. Acrivon Therapeutics, Common | Immunome vs. AnaptysBio |
Anixa Biosciences vs. Cue Biopharma | Anixa Biosciences vs. INmune Bio | Anixa Biosciences vs. In8bio Inc | Anixa Biosciences vs. PolyPid |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |